Minerva Neurosciences Announces Pricing Of Public Offering Of Common Stock
June 28, 2017 at 21:53 PM EDT
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock at a price to the public of $7.75 per share.
